Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea: Time-series analyses of a long-term multicenter cohort
- PMID: 36183907
- PMCID: PMC9532238
- DOI: 10.1016/j.jinf.2022.09.026
Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea: Time-series analyses of a long-term multicenter cohort
Keywords: Acinetobacter bauimanii; COVID-19; Carbapenem-resistant Enterobacterales; Multidrug-resistant bacteria; Pseudomonas aeruginosa; Vancomycin-resistant Enterococci.
Figures
Comment in
-
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020.J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.038. Epub 2022 Nov 3. J Infect. 2023. PMID: 36336172 No abstract available.
-
Multidrug-resistant infection in COVID-19 patients: A meta-analysis.J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.043. Epub 2022 Nov 5. J Infect. 2023. PMID: 36347426 Free PMC article. No abstract available.
-
Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan.J Infect. 2023 Jun;86(6):e161-e163. doi: 10.1016/j.jinf.2023.03.022. Epub 2023 Mar 30. J Infect. 2023. PMID: 37003522 Free PMC article. No abstract available.
References
-
- Lemenand O., Coeffic T., Thibaut S., Colomb Cotinat M., Caillon J., Birgand G. Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France. J Infect. 2021;83:664–670. - PubMed
-
- Taylor L. COVID-19: antimicrobial misuse in Americas sees drug resistant infections surge, says WHO. BMJ. 2021;375:n2845. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
